Skip to main content
. 2012 Mar 22;8:18. doi: 10.1186/1744-8069-8-18

Figure 1.

Figure 1

Subcutaneous morphine increases GFAP immunoreactivity in DRG SGCs. (A, B) GFAP immunoreactivity in DRGs from saline (A) or morphine (B, 10 mg/kg, s.c.) treated mice at 2 h after the injections. Left panels are images with high contrast showing all DRG cells in an optic field. Middle and right panels are low and high magnification images of GFAP staining. Note there is a marked increase in GFAP staining after acute morphine treatment. Scales, 50 μm.